Parallel Stock

liveparallel.comHealthcare / Other HealthcareFounded: 2014Funding to Date: $228.07MM

Founded in 2014, Parallel is a privately-held company with a focus on cannabis products and cannabis research and development. The mission of the organization is to improve quality of life through the use cannabinoids. Based in Atlanta, GA, the company focuses on all facets of the cannabis supply chain such as cultivation, production, distribution and retail. Parallel has additional facilities in Massachusetts, Florida, Texas, and Budapest, Hungary.

Register To Buy and Sell Shares

For more details on financing and valuation for Parallel, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Parallel’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Parallel.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

James Whitcomb
Chief Development Officer & Board Member
Lee Applbaum
Chief Marketing Officer
James Holmes III
Chief Strategy Officer & Board Member
William Wrigley Jr.
Chief Executive Officer & Chairman
Stevens Sainte-Rose
Chief Human Resources Officer
Edward Brown
Chief Brand Officer & Board Member
Neil Hampshire
Chief Information Officer
Kevin Fisher
Chief Operating Officer & Board Member
Fareed Khan
Chief Financial Officer

Board Members

James Holmes III
William Wrigley Jr.
Parallel (Healthcare)
James Whitcomb
Parallel (Healthcare)
Thomas Venables
Parallel (Healthcare)
Jason Becker
Parallel (Healthcare)
Kevin Fisher
Parallel (Healthcare)
Edward Brown
Parallel (Healthcare)

Parallel’s stock FAQs


Can you buy Parallel’s stock?

Parallel is not publicly traded on NYSE or NASDAQ in the U.S. To buy Parallel’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Parallel’s stock?

Yes, you can sell stock of a private company like Parallel. Forge can help you sell your Parallel stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Parallel’s stock price?

Parallel is a privately held company and therefore does not have a public stock price. However, you may access Parallel’s private market stock price with Forge Data.

What is Parallel’s stock ticker symbol?

Parallel does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Parallel Bets, Microsoft, and AI Strategies

The article explores Microsoft's strategy of parallel investments across various AI technologies and its implications. It discusses how Microsoft's diverse portfolio of AI investments, including its $3 billion stake in OpenAI and its extensive in-house AI operations, have helped the company stay competitive and adaptable in a rapidly evolving market. The article also contrasts Microsoft's strategy with Amazon's more concentrated bet on the Alexa digital assistant.

Parallel raises $1.85M pre-seed led by Penny Jar

Parallel, a company developing a solution for finance teams to streamline headcount forecasting, has raised $1.85M in pre-seed funding. The round was led by Penny Jar Capital, with participation from Convoi Ventures, Peak Capital, the Frazier group, and others. Parallel aims to unify disparate systems, providing a tool that syncs with HR and payroll data to improve accuracy and efficiency in financial forecasting.
Updated on: Jun 22, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.